American Research & Management Co. Celularity Inc Transaction History

American Research & Management Co.

  • $362 Million
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
BUY
$2.81 - $12.91 $168 - $774
60 Added 120.0%
110 $0
Q4 2021

Jan 28, 2022
BUY
$4.64 - $7.46 $231 - $373
50 New
50 $0

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track American Research & Management Co. Portfolio

Follow American Research & Management Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email